{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T10:29:43Z","timestamp":1790504983253,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.autrev.2006.09.010","type":"journal-article","created":{"date-parts":[[2006,10,3]],"date-time":"2006-10-03T12:04:53Z","timestamp":1159877093000},"page":"138-142","source":"Crossref","is-referenced-by-count":78,"title":["Autoantibody responses to melanocytes in the depigmenting skin disease vitiligo"],"prefix":"10.1016","volume":"6","author":[{"given":"E. Helen","family":"Kemp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikos G.","family":"Gavalas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Gawkrodger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony P.","family":"Weetman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2006.09.010_bib1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/archderm.113.1.47","article-title":"Prevalence of vitiligo: epidemiological survey on the Isle of Bornholm, Denmark","volume":"113","author":"Howitz","year":"1977","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.autrev.2006.09.010_bib2","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1001\/archderm.129.8.994","article-title":"Pattern of familial aggregation of vitiligo","volume":"129","author":"Majumder","year":"1993","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.autrev.2006.09.010_bib3","series-title":"Topics in dermatology","first-page":"257","article-title":"Vitiligo and other hypomelanoses of hair and skin","author":"Ortonne","year":"1983"},{"key":"10.1016\/j.autrev.2006.09.010_bib4","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0190-9622(96)90112-7","article-title":"Psychologic effects of vitiligo: a critical incident analysis","volume":"35","author":"Kent","year":"1996","journal-title":"J Am Acad Dermatol"},{"issue":"Supplement 8","key":"10.1016\/j.autrev.2006.09.010_bib5","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1034\/j.1600-0749.13.s8.9.x","article-title":"Intrinsic and extrinsic pathomechanisms in vitiligo","volume":"13","author":"Taeib","year":"2000","journal-title":"Pigment Cell Res"},{"key":"10.1016\/j.autrev.2006.09.010_bib6","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/286617a0","article-title":"New regulation of melanin biosynthesis and autodestruction of melanoma cells","volume":"286","author":"Pawelek","year":"1980","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2006.09.010_bib7","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1001\/archderm.118.1.5","article-title":"Vitiligo. It is important","volume":"118","author":"Nordlund","year":"1982","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.autrev.2006.09.010_bib8","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1111\/1523-1747.ep12492612","article-title":"Low catalase levels in the epidermis of patients with vitiligo","volume":"97","author":"Schallreuter","year":"1991","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2006.09.010_bib9","doi-asserted-by":"crossref","first-page":"935","DOI":"10.7326\/0003-4819-71-5-935","article-title":"Vitiligo in Graves' disease","volume":"71","author":"Ochi","year":"1969","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.autrev.2006.09.010_bib10","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1084\/jem.158.1.246","article-title":"Antibodies to normal human melanocytes in vitiligo","volume":"158","author":"Naughton","year":"1983","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2006.09.010_bib11","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1084\/jem.188.6.1203","article-title":"High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo","volume":"188","author":"Ogg","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2006.09.010_bib12","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1600-0625.1993.tb00023.x","article-title":"Review of the etiopathomechanism of vitiligo: a convergence theory","volume":"2","author":"Le Poole","year":"1993","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.autrev.2006.09.010_bib13","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/j.1468-3083.2005.01295.x","article-title":"Assessment of the immune system in 55 Iranian patients with vitiligo","volume":"19","author":"Farrokhi","year":"2005","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.autrev.2006.09.010_bib14","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/1523-1747.ep12522891","article-title":"Detection of antibodies to melanocytes in vitiligo by specific immunoprecipitation","volume":"81","author":"Naughton","year":"1983","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2006.09.010_bib15","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1111\/1523-1747.ep12492607","article-title":"Relation between the incidence and level of pigment cell antibodies and disease activity in vitiligo","volume":"97","author":"Harning","year":"1991","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2006.09.010_bib16","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/S0190-9622(86)70260-0","article-title":"Correlation between vitiligo antibodies and extent of depigmentation in vitiligo","volume":"15","author":"Naughton","year":"1986","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.autrev.2006.09.010_bib17","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/1523-1747.ep12476728","article-title":"Coexistence and relationship of antikeratinocyte and antimelanocyte antibodies in patients with non-segmental-type vitiligo","volume":"100","author":"Yu","year":"1993","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2006.09.010_bib18","first-page":"475","article-title":"Association of IgA anti-melanoma antibodies in the sera of vitiligo patients with active disease","volume":"88","author":"Aronson","year":"1987","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2006.09.010_bib19","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/1523-1747.ep12555773","article-title":"Identification of pigment cell antigens defined by vitiligo antibodies","volume":"98","author":"Cui","year":"1992","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2006.09.010_bib20","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1600-0749.1995.tb00774.x","article-title":"Characterisation of vitiligo antigens","volume":"8","author":"Cui","year":"1995","journal-title":"Pigment Cell Res"},{"key":"10.1016\/j.autrev.2006.09.010_bib21","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0923-1811(95)00427-0","article-title":"Identification of autoantibody to melanocytes and characterisation of vitiligo antigen in vitiligo patients","volume":"11","author":"Park","year":"1996","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.autrev.2006.09.010_bib22","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1046\/j.1365-4362.2000.00089.x","article-title":"Recognition of melanoma cell antigens with antibodies present from patients with vitiligo","volume":"39","author":"Rocha","year":"2002","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.autrev.2006.09.010_bib23","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(94)91709-4","article-title":"The role of tyrosinase in autoimmune vitiligo","volume":"344","author":"Song","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2006.09.010_bib24","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1046\/j.1365-2249.1996.d01-727.x","article-title":"Tyrosinase as an autoantigen in patients with vitiligo","volume":"105","author":"Baharav","year":"1996","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2006.09.010_bib25","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/1523-1747.ep12276556","article-title":"Detection of tyrosinase autoantibodies in vitiligo patients using 35S-labelled recombinant human tyrosinase in a radioimmunoassay","volume":"109","author":"Kemp","year":"1997","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2006.09.010_bib26","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1001\/archderm.135.4.417","article-title":"Vitiligo antibodies are not directed to tyrosinase","volume":"135","author":"Xie","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.autrev.2006.09.010_bib27","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1046\/j.1365-2249.1997.4781381.x","article-title":"Immunoprecipitation of melanogenic enzyme autoantigens with vitiligo sera: evidence for cross-reactive autoantibodies to tyrosinase and tyrosinase-related protein-2 (TRP-2)","volume":"109","author":"Kemp","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2006.09.010_bib28","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1046\/j.1523-1747.1998.00411.x","article-title":"Anti-tyrosinase-related protein-2 immune response in vitiligo and melanoma patients receiving active-specific immunotherapy","volume":"111","author":"Okamoto","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2006.09.010_bib29","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1046\/j.1365-2133.1998.02503.x","article-title":"Autoantibodies to tyrosinase-related protein-1 detected in the sera of vitiligo patients using a quantitative radiobinding assay","volume":"139","author":"Kemp","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2006.09.010_bib30","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1046\/j.1365-2249.1998.00746.x","article-title":"Autoantibodies to human melanocyte-specific protein Pmel17 in the sera of vitiligo patients: a sensitive and quantitative radioimmunoassay (RIA)","volume":"114","author":"Kemp","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2006.09.010_bib31","doi-asserted-by":"crossref","first-page":"35390","DOI":"10.1074\/jbc.M102391200","article-title":"The transcription factors SOX9 and SOX10 are melanocyte autoantigens related to vitiligo in autoimmune polyendocrine syndrome type 1","volume":"276","author":"Hedstrand","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2006.09.010_bib32","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1172\/JCI0214643","article-title":"The melanin-concentrating hormone receptor 1, a novel target of autoantibody responses in vitiligo","volume":"109","author":"Kemp","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2006.09.010_bib33","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1046\/j.1523-1747.2003.12494.x","article-title":"Autoantibodies in vitiligo patients recognise multiple domains of the melanin-concentrating hormone receptor","volume":"121","author":"Gottumukkala","year":"2003","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2006.09.010_bib34","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/1523-1747.ep12461505","article-title":"Evidence for immunologic mechanisms in human vitiligo: patients' sera induce damage to human melanocyes in vitro by complement-mediated damage and antibody-dependent cellular cytotoxicity","volume":"90","author":"Norris","year":"1988","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2006.09.010_bib35","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/1523-1747.ep12324456","article-title":"In vivo destruction of melanocytes by the IgG fraction of serum from patients with vitiligo","volume":"105","author":"Gilhar","year":"1995","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2006.09.010_bib36","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/labinvest.3700438","article-title":"Function blocking autoantibodies to the melanin-concentrating hormone receptor in vitiligo patients","volume":"86","author":"Gottumukkala","year":"2006","journal-title":"Lab Invest"},{"key":"10.1016\/j.autrev.2006.09.010_bib37","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1002\/1097-0142(19931015)72:8<2365::AID-CNCR2820720812>3.0.CO;2-G","article-title":"Vitiligo autoantibodies are effective against melanoma","volume":"72","author":"Fishman","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.autrev.2006.09.010_bib38","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S0006-291X(02)00932-4","article-title":"Melanin-concentrating hormone and its receptor are expressed and functional in human skin","volume":"296","author":"Hoogduijn","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.autrev.2006.09.010_bib39","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1600-0749.1988.tb00801.x","article-title":"Enhanced susceptibility of melanocytes to different immunologic effector mechanisms in vitro: potential mechanisms for post-inflammatory hypopigmentation and vitiligo","volume":"1","author":"Norris","year":"1988","journal-title":"Pigment Cell Res"},{"key":"10.1016\/j.autrev.2006.09.010_bib40","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.autrev.2006.03.012","article-title":"Therapeutic implications of autoimmune vitiligo cells","volume":"5","author":"Oyarbide-Valencia","year":"2006","journal-title":"Autoimmun Rev"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997206001662?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997206001662?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,21]],"date-time":"2019-04-21T12:14:01Z","timestamp":1555848841000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997206001662"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S1568997206001662"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2006.09.010","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}